- Mammalian target of rapamycin inhibition in polycystic kidney disease: From bench to bedside
-
Kim HJ, Edelstein
- KMID: 2224211
- Kidney Res Clin Pract.
- 2012 Sep;31(3):132-138.
Autosomal dominant polycystic kidney disease (ADPKD) is the most common life-threatening hereditary disease in the USA resulting in chronic kidney disease and the need for dialysis and transplantation. Approximately 85%... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in Asian Subjects with Human Immunodeficiency Virus 1 Infection: A Sub-Analysis of Phase 3 Clinical Trials
-
Choi JY, Sungkanuparph S, Anekthananon T, Sax P, DeJesus E, Edelstein , Nelson M, DeMorin J, Liu HC, Swamy R, Bahn J, Hwang S, Yang SY, Ng C, Piontkowsky D
- KMID: 2466435
- Infect Chemother.
- 2016 Sep;48(3):219-224.
- doi: 10.3947/ic.2016.48.3.219
The efficacy and safety of a single tablet regimen (STR) of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate (E/C/F/TDF) were analyzed in Phase 3 clinical trials in antiretroviral therapy (ART)-naïve and ART-experienced Asian subjects... -
- CITED
-
- Close
- SHARE
-
- Close
